{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:01:11Z","timestamp":1753891271280,"version":"3.41.2"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Tuberous sclerosis complex (TSC) is a rare autosomal dominant genetic disease with systemic organ involvement. So far, only a few TSC families in China have been reported. Therefore, more data on the clinical and genetic features of TSC families are required.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>We retrospectively analyzed 12 TSC family probands and their family members. Next-generation sequencing (NGS) has been applied to confirm the type of TSC mutation along with a detailed physical examination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In this study, twenty-seven patients in 12 TSC families were reported, including 12 male and 15 female patients, aged 8\u201367 years. Skin lesions were detected among all patients with TSC, including 25 cases of facial angiofibromas, 18 cases of hypomelanotic macules, 15 cases of ungual fibromas, and 13 cases of shagreen patch. Other clinical features were also revealed: 14 cases of renal angiomyolipoma, 6 cases of subependymal nodules (SENs), and 3 cases of lymphangioleiomyomatosis. All twenty-seven patients with TSC were tested by NGS. Totally, <jats:italic>TSC2<\/jats:italic> mutations were reported in 19 cases (7 frameshift mutations, 10 nonsense mutations, and 2 missense mutations), <jats:italic>TSC1<\/jats:italic> mutations were reported in 4 cases (4 nonsense mutations), and 4 cases were genetically negative. The novel causal mutations (<jats:italic>TSC2<\/jats:italic>: c.208dup, c.1874C &amp;gt; G, c.1852del) identified in three families were first reported in TSC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings expand the mutation spectrum of patients with TSC in China. The clinical characteristics can vary among patients with TSC with the same pathogenic mutation. The genetic results and summary of clinical features of 12 TSC families contribute to a more accurate diagnosis and further genetic counseling.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.840709","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T09:10:26Z","timestamp":1654074626000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of Clinical Features and Next-Generation Sequencing of 12 Tuberous Sclerosis Families in China"],"prefix":"10.3389","volume":"9","author":[{"given":"Xu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenda","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yushi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat Rev Dis Primer."},{"key":"B2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/ajmg.c.31654","article-title":"Renal manifestation of tuberous sclerosis complex","volume":"178","author":"Bissler","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"B3","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1136\/archdischild-2016-312001","article-title":"Cutaneous manifestations of tuberous sclerosis complex and the paediatrician's role","volume":"102","author":"Cardis","year":"2017","journal-title":"Arch Dis Child."},{"key":"B4","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S1474-4422(15)00069-1","article-title":"Neurological and neuropsychiatric aspects of tuberous sclerosis complex","volume":"14","author":"Curatolo","year":"2015","journal-title":"Lancet Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1471-2261-14-66","article-title":"Rhabdomyomas and tuberous sclerosis complex: our experience in 33 cases","volume":"14","author":"Sciacca","year":"2014","journal-title":"BMC Cardiovasc Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/ajmg.c.31638","article-title":"Pulmonary manifestations in tuberous sclerosis complex","volume":"178","author":"Gupta","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/ceo.12806","article-title":"Ophthalmic manifestations of tuberous sclerosis: a review","volume":"45","author":"Hodgson","year":"2017","journal-title":"Clin Exp Ophthalmol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.pediatrneurol.2013.08.001","article-title":"Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Northrup","year":"2013","journal-title":"Pediatr Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejpn.2015.11.011","article-title":"The clinical profile of tuberous sclerosis complex (TSC) in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD)","volume":"20","author":"Kingswood","year":"2016","journal-title":"Eur J Paediatr Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.yebeh.2018.03.006","article-title":"Characteristics and healthcare situation of adult patients with tuberous sclerosis complex in German epilepsy centers","volume":"82","author":"Hamer","year":"2018","journal-title":"Epilepsy Behav EB."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0204646","DOI":"10.1371\/journal.pone.0204646","article-title":"Observational study of characteristics and clinical outcomes of Dutch patients with tuberous sclerosis complex and renal angiomyolipoma treated with everolimus","volume":"13","author":"Zonnenberg","year":"2018","journal-title":"PLoS ONE."},{"key":"B12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev-genom-083118-015354","article-title":"Genetic etiologies, diagnosis, and treatment of tuberous sclerosis complex","volume":"20","author":"Salussolia","year":"2019","journal-title":"Annu Rev Genomics Hum Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","article-title":"Tuberous sclerosis","volume":"372","author":"Curatolo","year":"2008","journal-title":"Lancet Lond Engl."},{"key":"B14","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.urology.2016.10.056","article-title":"Assessment of tuberous sclerosis complex associated with renal lesions by targeted next-generation sequencing in Mainland China","volume":"101","author":"Cai","year":"2017","journal-title":"Urology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"Dabora","year":"2001","journal-title":"Am J Hum Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1590\/abd1806-4841.20186972","article-title":"Tuberous sclerosis complex: review based on new diagnostic criteria","volume":"93","author":"Portocarrero","year":"2018","journal-title":"An Bras Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.ejpn.2018.05.006","article-title":"Management of epilepsy associated with tuberous sclerosis complex: updated clinical recommendations","volume":"22","author":"Curatolo","year":"2018","journal-title":"Eur J Paediatr Neurol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13023-016-0553-5","article-title":"TuberOus SClerosis registry to increase disease Awareness (TOSCA) - baseline data on 2093 patients","volume":"12","author":"Kingswood","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/ajmg.c.31652","article-title":"Current concepts on epilepsy management in tuberous sclerosis complex","volume":"178","author":"Canevini","year":"2018","journal-title":"Am J Med Genet C Semin Med Genet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41581-018-0059-6","article-title":"Renal disease in tuberous sclerosis complex: pathogenesis and therapy","volume":"14","author":"Lam","year":"2018","journal-title":"Nat Rev Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5301\/JN.2010.5451","article-title":"Renal epithelioid angiomyolipoma: a malignant disease","volume":"24","author":"Varma","year":"2011","journal-title":"J Nephrol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.purol.2009.01.010","article-title":"Renal epithelioid angiomyolipoma","volume":"19","author":"Lopater","year":"2009","journal-title":"Prog Urol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet Lond Engl."},{"key":"B24","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.juro.2016.09.082","article-title":"Pediatric renal angiomyolipomas in tuberous sclerosis complex","volume":"197","author":"Warncke","year":"2017","journal-title":"J Urol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.2215\/CJN.08150816","article-title":"Treatment of renal angiomyolipoma and other hamartomas in patients with tuberous sclerosis complex","volume":"12","author":"Samuels","year":"2017","journal-title":"Clin J Am Soc Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13023-019-1012-x","article-title":"Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis","volume":"14","author":"Li","year":"2019","journal-title":"Orphanet J Rare Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1164\/rccm.201607-1384ST","article-title":"Official American Thoracic Society\/Japanese Respiratory Society Clinical Practice Guidelines: lymphangioleiomyomatosis diagnosis and management","volume":"194","author":"McCormack","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e0228894","DOI":"10.1371\/journal.pone.0228894","article-title":"Estrogen activates pyruvate kinase M2 and increases the growth of TSC2-deficient cells","volume":"15","author":"Lu","year":"2020","journal-title":"PLoS ONE."},{"key":"B30","doi-asserted-by":"publisher","first-page":"e0185713","DOI":"10.1371\/journal.pone.0185713","article-title":"Molecular analysis of TSC1 and TSC2 genes and phenotypic correlations in Brazilian families with tuberous sclerosis","volume":"12","author":"Rosset","year":"2017","journal-title":"PLoS ONE."},{"key":"B31","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1600-0404.2004.00366.x","article-title":"Mutation and polymorphism analysis of TSC1 and TSC2 genes in Indian patients with tuberous sclerosis complex","volume":"111","author":"Ali","year":"2005","journal-title":"Acta Neurol Scand."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1006242","DOI":"10.1371\/journal.pgen.1006242","article-title":"Whole exome sequencing identifies TSC1\/TSC2 biallelic loss as the primary and sufficient driver event for renal angiomyolipoma development","volume":"12","author":"Giannikou","year":"2016","journal-title":"PLoS Genet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1469-1809.1999.6350383.x","article-title":"Superiority of denaturing high performance liquid chromatography over single-stranded conformation and conformation-sensitive gel electrophoresis for mutation detection in TSC2","volume":"63","author":"Choy","year":"1999","journal-title":"Ann Hum Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1046\/j.1469-1809.1998.6240277.x","article-title":"Comprehensive mutational analysis of the TSC1 gene: observations on frequency of mutation, associated features, and nonpenetrance","volume":"62","author":"Kwiatkowska","year":"1998","journal-title":"Ann Hum Genet."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.840709\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T09:10:27Z","timestamp":1654074627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.840709\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":34,"alternative-id":["10.3389\/fmed.2022.840709"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.840709","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,5,27]]},"article-number":"840709"}}